Invention Grant
US09359364B2 Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one
有权
涉及1-乙基-7-（2-甲基-6-（1H-1,2,4-三唑-3-基）吡啶-3-基）-3的药物制剂，方法，固体形式和使用方法， 2,3-二氢吡嗪并[2,3-b]吡嗪-2（1H） - 酮
![Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one](/docs/US/2016-06-07/US09359364B2/abs.jpg.600x600.jpg)
- Patent Title: Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one
- Patent Title (中): 涉及1-乙基-7-（2-甲基-6-（1H-1,2,4-三唑-3-基）吡啶-3-基）-3的药物制剂，方法，固体形式和使用方法， 2,3-二氢吡嗪并[2,3-b]吡嗪-2（1H） - 酮
-
Application No.: US14254023Application Date: 2014-04-16
-
Publication No.: US09359364B2Publication Date: 2016-06-07
- Inventor: Anil Menon , Darshan K. Parikh , Dora Visky , Matthew Michael Kreilein , Nathan Boersen , Thomas Lee , Ying Li , Jean Xu , Xiaozhang Liang , William Wei-Hwa Leong , Benjamin Cohen
- Applicant: SIGNAL PHARMACEUTICALS, LLC
- Applicant Address: US CA San Diego
- Assignee: Signal Pharmaceuticals, LLC
- Current Assignee: Signal Pharmaceuticals, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4985 ; C07D471/04 ; A61K9/20 ; A61K9/48
![Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one](/abs-image/US/2016/06/07/US09359364B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.
Public/Granted literature
Information query
